Catalogo Articoli (Spogli Riviste)

HELP
ATTENZIONE: attualmente gli articoli Current Contents (fonte ISI) a partire dall'anno 2002 sono consultabili sulla Risorsa On-Line

Le informazioni sugli articoli di fonte ISI sono coperte da copyright

La ricerca find articoli where soggetti phrase all words 'REVERSIBLE INHIBITOR' sort by level,fasc_key/DESCEND, pagina_ini_num/ASCEND ha restituito 38 riferimenti
Selezionare un intervallo

Per ulteriori informazioni selezionare i riferimenti di interesse.

    1. Connor, KM; Hidalgo, RB; Crockett, B; Malik, M; Katz, RJ; Davidson, JRT
      Predictors of treatment response in patients with posttraumatic stress disorder

      PROGRESS IN NEURO-PSYCHOPHARMACOLOGY & BIOLOGICAL PSYCHIATRY
    2. Ohishi, N; Suzuki, T; Ogasawara, T; Yagi, K
      Xanthone derivatives as inhibitors for monoamine oxidase

      JOURNAL OF MOLECULAR CATALYSIS B-ENZYMATIC
    3. Pozdnev, VF; Axenova, LN; Medvedev, AE
      Monoamine oxidase inhibition by N-alkyloxycarbonyl derivatives of ethylenediamine

      BIOCHEMISTRY-MOSCOW
    4. De Tullio, P; Ceccato, A; Liegeois, JF; Pirotte, B; Felikidis, A; Hubert, P; Crommen, J; Geczy, J; Delarge, J
      Effective resolution of racemic pirlindole at the preparative scale

      CHIRALITY
    5. Herzog, ED; Block, GD
      Keeping an eye on retinal clocks

      CHRONOBIOLOGY INTERNATIONAL
    6. Kim, SR; Hwang, SY; Jang, YP; Park, MJ; Markelonis, GJ; Oh, TH; Kim, YC
      Protopine from Corydalis ternata has anticholinesterase and antiamnesic activities

      PLANTA MEDICA
    7. Okuyama, E; Homma, M; Satoh, Y; Fujimoto, H; Ishibashi, M; Yamazaki, M; Satake, M; Ghazali, AB
      Monoamine oxidase inhibitory naphthoquinone and/or naphthalene dimers fromLemuni Hitam (Diospyros sp.), a Malaysian herbal medicine

      CHEMICAL & PHARMACEUTICAL BULLETIN
    8. JEGHAM S; GEORGE P
      MONOAMINE-OXIDASE A AND B INHIBITORS

      Expert opinion on therapeutic patents
    9. Bruhwyler, J; Liegeois, JF; Gerardy, J; Damas, J; Chleide, E; Lejeune, C; Decamp, E; de Tullio, P; Delarge, J; Dresse, A; Geczy, J
      Comparative study of pirlindole, a selective RIMA, and its two enantiomersusing biochemical and behavioural techniques

      BEHAVIOURAL PHARMACOLOGY
    10. Ceccato, A; Hubert, P; de Tullio, P; Liegeois, JF; Felikidis, A; Geczy, J; Crommen, J
      Enantiomeric separation of pirlindole by liquid chromatography using different types of chiral stationary phases

      JOURNAL OF PHARMACEUTICAL AND BIOMEDICAL ANALYSIS
    11. Ceccato, A; Hubert, P; de Tullio, P; Liegois, JF; Stachow, M; Geczy, J; Crommen, J
      Simultaneous determination of pirlindole enantiomers and dehydropirlindoleby chiral liquid chromatography

      JOURNAL OF PHARMACEUTICAL AND BIOMEDICAL ANALYSIS
    12. GERARDY J; DRESSE A
      REGIONAL ACTION OF BROFAROMINE ON RAT-BRAIN MAO-A AND MAO-B

      Progress in neuro-psychopharmacology & biological psychiatry
    13. MEDVEDEV AE; VESELOVSKY AV; SHVEDOV VI; TIKHONOVA OV; MOSKVITINA TA; FEDOTOVA OA; AXENOVA LN; KAMYSHANSKAYA NS; KIRKEL AZ; IVANOV AS
      INHIBITION OF MONOAMINE-OXIDASE BY PIRLINDOLE ANALOGS - 3D-QSAR AND COMFA ANALYSIS

      Journal of chemical information and computer sciences
    14. FERIGOLO M; BARROS HMT; MARQUARDT AR; TANNHAUSER M
      COMPARISON OF BEHAVIORAL-EFFECTS OF MOCLOBEMIDE AND DEPRENYL DURING FORCED SWIMMING

      Pharmacology, biochemistry and behavior
    15. MORI S; ZANARDI R; POPOLI M; GARBINI S; BRUNELLO N; SMERALDI E; RACAGNI G; PEREZ J
      CAMP-DEPENDENT PHOSPHORYLATION SYSTEM AFTER SHORT AND LONG-TERM ADMINISTRATION OF MOCLOBEMIDE

      Journal of Psychiatric Research
    16. BRUHWYLER J; LIEGEOIS JF; GECZY J
      PIRLINDOLE - A SELECTIVE REVERSIBLE INHIBITOR OF MONOAMINE-OXIDASE-A - A REVIEW OF ITS PRECLINICAL PROPERTIES

      Pharmacological research
    17. KATO M; IWATA H; KATAYAMA T; ASAI H; NARITA H; ENDO T
      POSSIBLE THERAPEUTIC EFFECT OF T-794, A NOVEL REVERSIBLE INHIBITOR OFMONOAMINE OXIDASE-A, ON POSTSTROKE EMOTIONAL DISTURBANCES, ASSESSED IN ANIMAL-MODELS OF DEPRESSION

      Biological & pharmaceutical bulletin
    18. DEWILDE J; MERTENS C; VANDORPE J; BRUHWYLER J; GECZY J
      DOUBLE-BLIND RANDOMIZED CONTROLLED PILOT-STUDY OF THE EFFICACY AND TOLERABILITY OF PIRLINDOLE, A REVERSIBLE INHIBITOR OF MONOAMINE-OXIDASE-A, AND MIANSERIN, IN THE TREATMENT OF DEPRESSION

      Human psychopharmacology
    19. IWATA N; PUCHLER K; PLENKER A
      PHARMACOLOGY OF THE NEW REVERSIBLE INHIBITOR OF MONOAMINE-OXIDASE-A, RS-8359

      International clinical psychopharmacology
    20. PUCHLER K; SCHAFFLER K; PLENKER A
      THE COMPARATIVE EFFECTS OF SINGLE AND MULTIPLE DOSES OF RS-8359, MOCLOBEMIDE AND PLACEBO ON PSYCHOMOTOR FUNCTION IN HEALTHY-SUBJECTS

      International clinical psychopharmacology
    21. PLENKER A; PUCHLER K; VOLZ HP
      THE EFFECTS OF RS-8359 ON CARDIOVASCULAR FUNCTION IN HEALTHY-SUBJECTSAND DEPRESSED-PATIENTS

      International clinical psychopharmacology
    22. PUCHLER K; PLENKER A; VOLZ HP
      SAFETY, TOLERABILITY AND EFFICACY OF THE REVERSIBLE MONOAMINE-OXIDASEINHIBITOR RS-8359 IN EARLY CLINICAL-TRIALS

      International clinical psychopharmacology
    23. CHEMNITIUS JM; SCHAHMIRZADI F; GONSKA BD; KREUZER H; ZECH R
      INDIRECT PARASYMPATHOMIMETIC ACTIVITY OF THE CLASS-III ANTIARRHYTHMICSUBSTANCE D L-SOTALOL IN-VITRO - REVERSIBLE INHIBITION OF CHOLINESTERASE ISOENZYMES FROM BLOOD AND THE HUMAN CENTRAL-NERVOUS-SYSTEM/

      Pharmacological research
    24. CHEMNITIUS JM; HASELMEYER KH; GONSKA BD; KREUZER H; ZECH R
      INDIRECT PARASYMPATHOMIMETIC ACTIVITY OF METOCLOPRAMIDE - REVERSIBLE INHIBITION OF CHOLINESTERASES FROM HUMAN CENTRAL-NERVOUS-SYSTEM AND BLOOD

      Pharmacological research
    25. VOLZ HP; GLEITER CH; WALDMEIER PC; STRUCK M; MOLLER HJ
      BROFAROMINE - A REVIEW OF ITS PHARMACOLOGICAL PROPERTIES AND THERAPEUTIC USE

      Journal of neural transmission
    26. MIURA H; NAOI M; NAKAHARA D; OHTA T; NAGATSU T
      EFFECTS OF MOCLOBEMIDE ON FORCED-SWIMMING STRESS AND BRAIN MONOAMINE LEVELS IN MICE

      Pharmacology, biochemistry and behavior
    27. VOLZ HP; GLEITER CH; STRUCK M; MOLLER HJ
      BROFAROMINE - INSIGHT INTO THE NATURE OF DRUG DEVELOPMENT

      CNS DRUGS
    28. BOS M; CANESSO R; KETTLER R; KELLER HH; SCHONHOLZER P
      RESOLUTION, EPC-SYNTHESES, ABSOLUTE STEREOCHEMISTRY, AND PHARMACOLOGYOF THE (S)-(-ISOMERS ACID (R)-(-)-ISOMERS OF THE MAO-A INHIBITOR TETRINDOLE HYDROCHLORIDE())

      Archiv der pharmazie
    29. ULUGOL A; KARADAG HC; DOKMECI D; ALKHATIB I; DOKMECI I
      THE PROTECTIVE EFFECT OF MOCLOBEMIDE AGAINST HYPOXIA-INDUCED LETHALITY IN MICE IS NOT DUE TO A DECREASE IN BODY-TEMPERATURE

      Pharmacology, biochemistry and behavior
    30. UCHIDA M; OTSUBO K; MATSUBARA J; OHTANI T; MORITA S; YAMASAKI K
      SYNTHESIS OF 4-(PHENYLAMINO)QUINOLINE-3-CARBOXAMIDES AS A NOVEL CLASSOF GASTRIC H+ K+-ATPASE INHIBITORS/

      Chemical and Pharmaceutical Bulletin
    31. PRIEST RG; GIMBRETT R; ROBERTS W; STEINERT J
      REVERSIBLE AND SELECTIVE INHIBITORS OF MONOAMINE-OXIDASE-A IN MENTAL AND OTHER DISORDERS

      Acta psychiatrica Scandinavica
    32. GACHOUD JP; DICK P; KOHLER M
      COMPARISON OF THE EFFICACY AND TOLERABILITY OF MOCLOBEMIDE AND MAPROTILINE IN DEPRESSED-PATIENTS TREATED BY GENERAL-PRACTITIONERS

      Clinical neuropharmacology
    33. VOLZ HP; FALTUS F; MAGYAR I; MOLLER HJ
      BROFAROMINE IN TREATMENT-RESISTANT DEPRESSED-PATIENTS - A COMPARATIVETRIAL VERSUS TRANYLCYPROMINE

      Journal of affective disorders
    34. LAVIAN G; FINBERG JPM; YOUDIM MBH
      THE ADVENT OF A NEW-GENERATION OF MONOAMINE-OXIDASE INHIBITOR ANTIDEPRESSANTS - PHARMACOLOGICAL STUDIES WITH MOCLOBEMIDE AND BROFAROMINE

      Clinical neuropharmacology
    35. HAEFELY W; BURKARD WP; CESURA A; COLZI A; KETTLER R; LOREZ HP; MARTIN JR; MOREAU JL; RICHARDS JG; SCHAFFNER R; SCHERSCHLICHT R; SEPINWALL J; DAPRADA M
      PHARMACOLOGY OF MOCLOBEMIDE

      Clinical neuropharmacology
    36. TILLER JWG
      CLINICAL OVERVIEW ON MOCLOBEMIDE

      Progress in neuro-psychopharmacology & biological psychiatry
    37. VALLES B; COASSOLO P; DESOUSA G; AUBERT C; RAHMANI R
      IN-VITRO HEPATIC BIOTRANSFORMATION OF MOCLOBEMIDE (RO 11-1163) IN MANAND RAT

      Xenobiotica
    38. ALEVIZOS B; HATZIMANOLIS J; MARKIANOS M; STEFANIS CN
      CLINICAL, ENDOCRINE AND NEUROCHEMICAL EFFECTS OF MOCLOBEMIDE IN DEPRESSED-PATIENTS

      Acta psychiatrica Scandinavica


ASDD Area Sistemi Dipartimentali e Documentali, Università di Bologna, Catalogo delle riviste ed altri periodici
Documento generato il 10/08/20 alle ore 18:46:19